In prostate cancer cells, RB inactivation increases cellular plasticity, which increases resistance to anti-androgen therapy and promotes metastasis via induction of SOX2, especially in a TP53-deficient background [29,30]. The gene discussed is RB1; the disease is Familial prostate cancer.